Today: 9 June 2026
UPL share price slips as Advanta IPO papers hit SEBI: what the filing reveals
20 January 2026
1 min read

UPL share price slips as Advanta IPO papers hit SEBI: what the filing reveals

Mumbai, Jan 20, 2026, 14:42 IST

  • Advanta, UPL’s seed division, submitted a draft prospectus for an IPO set up as an offer for sale.
  • The deal could involve as many as 36.1 million shares, with UPL set to offload up to 28.1 million.
  • UPL shares slipped nearly 8% in afternoon trading, trailing behind its sector peers.

UPL Ltd announced that its seed arm, Advanta Enterprises, submitted a draft red herring prospectus to the Securities and Exchange Board of India (SEBI) on Jan. 19. The IPO, planned as an offer for sale, could see up to 36,105,578 shares hit the market, with UPL intending to offload as many as 28,107,578.

The filing kicks off SEBI’s review and sets Advanta on course for a formal listing on Indian exchanges. For UPL, it offers a chance to offload part of its stake and establish a clearer market value for the business tucked inside its larger agrochemicals portfolio.

The planned IPO will be purely an offer-for-sale (OFS), with existing shareholders offloading shares and no fresh capital coming into the company, PTI reported. Among the sellers are UPL and investors Melwood Holdings II Pte Ltd and KIA EBT Scheme 2.

Advanta offers hybrid seeds and post-harvest solutions, marketing over 900 hybrid seed varieties across 74 countries, alongside its post-harvest unit, Decco, PTI reported. The company’s merchant bankers are JM Financial, Axis Capital, Citigroup Global Markets India, Goldman Sachs (India) Securities, and Morgan Stanley India Company, the report added.

UPL shares dropped steadily during trading. By 1:49 p.m. IST, the Economic Times live tracker showed the stock at 722.1 rupees, marking an 8.27% decline for the day.

MarketsMojo reported that UPL hit an intraday low of 741 rupees earlier, lagging behind the pesticides and agrochemicals sector, which fell 2.92%. The firm noted that while UPL remains above its 100-day and 200-day moving averages, it is trading below its shorter-term averages — a key technical indicator for trend direction.

UPL continues as Advanta’s promoter, though the offer size may shift as regulators review the draft and market conditions evolve. The draft prospectus is just the initial step; pricing and timing will be decided down the line.

However, a sale-only float tends to react sharply to market volatility and investor appetite for fresh shares. “The Offer is subject to receipt of necessary approvals, market conditions and other considerations,” UPL noted in its stock exchange filing. Economic Times

If the deal goes through, investors would gain a standalone public-market view of Advanta, while current shareholders could scale back their stakes. At this stage, the filing marks only the initial step.

Stock Market Today

  • Constant and Constant Advises Piraeus Bank on Safe Bulkers Euronext Athens Dual Listing
    June 9, 2026, 9:51 AM EDT. Constant and Constant Greece and UK firm TLT advised Piraeus Bank on the dual listing of Safe Bulkers, Inc. on Euronext Athens, marking the first Greek shipping company listed in New York to also trade on Athens' exchange. Safe Bulkers, a marine dry bulk carrier with 45 vessels, is now accessible to both U.S. and Greek investors. The legal teams led cross-border due diligence covering loan facilities, guarantees, and fleet agreements to ensure compliance. This move is expected to pave the way for similar listings, enhancing Greece's capital markets. Safe Bulkers' CFO praised the firms for precise, detailed legal support throughout the complex process.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
Unilever share price today: ULVR slides in London as tariff nerves linger ahead of results
Previous Story

Unilever share price today: ULVR slides in London as tariff nerves linger ahead of results

Intel stock slides premarket despite HSBC upgrade as tariff jitters hit tech
Next Story

Intel stock slides premarket despite HSBC upgrade as tariff jitters hit tech

Go toTop